Homology Medicines Inc (FIXX) is near the bottom in its industry group according to InvestorsObserver. FIXX gets an overall rating of 33. That means it scores higher than 33 percent of stocks. Homology Medicines Inc gets a 29 rank in the Biotechnology industry. Biotechnology is number 95 out of 148 industries.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 33 means the stock is more attractive than 33 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Homology Medicines Inc Stock Today?
Homology Medicines Inc (FIXX) stock is higher by 2.86% while the S&P 500 is lower by -0.03% as of 11:25 AM on Wednesday, Apr 14. FIXX has risen $0.21 from the previous closing price of $7.18 on volume of 507,967 shares. Over the past year the S&P 500 has risen 45.48% while FIXX is lower by -61.79%. FIXX lost -$2.80 per share the over the last 12 months.
Click Here to get the full Stock Score Report on Homology Medicines Inc (FIXX) Stock.
